From the Project CBD Archives:
PEA: Anti-Inflammatory Superstar
From the “Get to Know a Neurotransmitter” series: PEA, the endogenous CBD.
Encouraging Cancer Research
New studies highlight therapeutic potential of cannabinoids, but clinical trials are lacking.
CBD, PPARs & Gene Expression
CBD reduces brain and breast cancer cell proliferation and metastasis by inhibiting the ID-1 gene.
CBD for Pain: What Does the Science Say?
Excerpted from “CBD: What Does the Science Say?” by By Linda Parker, Erin M. Rock, and Raphael Mechoulam.
Scientific Research on CBD & Cannabis for Neuropathy:
- Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
- Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain
- Cannabis, pain, and sleep: Sativex Clinical Trials
- Sativex successfully treats neuropathic pain characterised by allodynia: clinical trial
- Cannabinoids for neuropathic pain
- Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue
- Oromucosal delta9-THC/CBD for neuropathic pain associated with multiple sclerosis
- The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
- Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
- Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain
- Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
- Cannabinoids in the management of difficult to treat pain